WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

China Releases Updated NRDL and First Commercial Insurance Innovative Drug Lis... China announced on December 7 the release of an updated National Reimbursement Drug List (NRDL) and the country's first Commercial Insurance Innovative Drug List, marking...
(12/8/2025)

China's New Drug Commercial Insurance Scheme O... (12/17/2025)

Innovative Drugs: The New Battleground in US-C... (12/11/2025)

Chinese Biopharma Sector Posts 22 Financings ... (12/11/2025)

China Tightens Oversight as Domestic Innovator... (12/11/2025)

Global Pharmas Turn to China Not Just for Asse... (12/9/2025)

China Launches National Drug Price Registratio... (12/2/2025)

NHC Releases 2024 China Health Statistics Bull... (12/2/2025)

China Used to Be a Cash Cow for Western Compan... (12/2/2025)

MNC's County-Level Ambitions Falter as Strateg... (12/1/2025)

LEK: China's Clinical Trial Sector Enters a Ne... (11/28/2025)

MC's China Biopharma Tracker: Dealmaking, Appr... (11/27/2025)

China's Biopharma Innovation Surges — McKinse... (11/21/2025)

China Moves to Prosecute Former Traditio... (12/17/2025) Ocgene Raises $30M Series B to Advance G... (12/17/2025) Allin Raises ~$50M in Series A+ to Adva... (12/17/2025) BMS Expands Antibody Pipeline Thru Globa... (12/17/2025) Hansoh and Glenmark Strike Multi-Regiona... (12/17/2025) GeneScience Signs Up to $1.37B Global Li... (12/16/2025) D3 Bio Raises $108M Series B to Advance... (12/16/2025) China Approves Genzyme's Fenthosilan Sod... (12/16/2025) Fosun Moves to Acquire Maker of Controve... (12/16/2025) Western Gene Therapy Developers Look to ... (12/16/2025) InnoCare's Orelabrutinib Hits Primary En... (12/16/2025) CDE Solicits Comments on First Batch of ... (12/15/2025) CDE Seeks Comments on Draft Technical Gu... (12/15/2025) KYinno Raises ~CNY 250M in Series B to... (12/15/2025) Qilu Advances GSPT1 Degrader ADC Progra... (12/15/2025) AusperBio Reports Promising Phase 2a Res... (12/15/2025) Qilu Wins Approval for China's First Ful... (12/15/2025) InnoCare Secures NMPA Approval for Pan-T... (12/15/2025)

China's Human Vaccine Market Set for Steady Long-Term E... China's Pharmaceutical Market Enters a New Consumer-Dri... China's Aging Population to Drive Trillion-Dollar Healt... China's Innovative Drug Market Shows Diverging Trends B... Innovent's Weight-Loss Drug Challenges Western Giants i...

Hansoh and Glenmark Strike Multi-Regional Licensing Dea... BMS Expands Antibody Pipeline Thru Global Collaboration... Allin Raises ~$50M in Series A+ to Advance Next-Gen AD... Ocgene Raises $30M Series B to Advance Global Mid-Stage... Western Gene Therapy Developers Look to China for Faste...

CDE Seeks Comments on Draft Technical Guidelines for Ge... CDE Solicits Comments on First Batch of ICH M13A Low-Ri... China Releases 99th Batch of Reference Formulations Cat... China Issues Revised Guideline on Grading Adverse Event... CDE Seeks Comments on Draft Guidelines Defining Major D...

NHSA Unveils Three-Year Plan to Accelerate BMI Fund Cle... China Pushes Private Insurance to Cover High-Cost Innov... China Releases Updated NRDL and First Commercial Insura... China's Healthcare Costs Shift to Individuals as Govern... China Expands Grassroots Healthcare Access with More Do...

BeOne and AbbVie Resolve Patent Dispute O... Several Chinese Biotech Firms Added to U.S. Entity List... Chinese Scientist Arrested in Houston Over Alleged Thef... U.S. Closes Bribery Investigation into GE Healthcare's ... SAMR Orders Simcere to Reverse Unnotified Merger Over C...

Abraham Accords Partners Could Help the U.S. Reduce Pha... PhIIC Report Highlights China's API Industry Rebound as... India and China Explore Reverse-Trade Model for Pharmac... Clariant Completes Expansion of Pharma Excipients and S... Sanofi Launches €1B Insulin API Manufacturing Project ...

InnoCare's Orelabrutinib Hits Primary Endpoint in Phase... China Approves Genzyme's Fenthosilan Sodium Injection InnoCare Secures NMPA Approval for Pan-TRK Inhibitor Zu... Qilu Wins Approval for China's First Fully Human Anti-E... AusperBio Reports Promising Phase 2a Results for AHB-13...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

China Moves to Prosecute Former Traditional Medicine Re... Recent Executive Moves Former CFDA Boss Bi Jingquan Expelled From Party, Faces... Recent Executive Moves Recent Executive Moves

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...